LEHI, UT, and SOUTH SAN FRANCISCO, CA – March 16, 2022—Lumea, the global leader in integrated digital pathology solutions and Verily, an Alphabet precision health company, today announced a strategic…
Read More
Why hasn’t digital pathology taken hold, and will it ever be viable for routine work? Every pathologist knows we’re supposed to be entering the age of digital pathology, yet the...
Read More
Alphabet’s life sciences arm, Verily, is partnering with the digital pathology platform Lumea to improve the objectivity and efficiency of prostate cancer diagnosis, prognosis, and therapy selection. Verily developed AI systems for…
U.S. Patent 11,173,489 US Abstract Tissue sample cassettes for receiving tissue samples include an upper tray including compartments separated by dividers, a lower tray coupled to the upper tray and…
TruCore Pathology is a team of board-certified, expert pathologists. They use Lumea’s proprietary tissue-handling technology to get larger, higher-quality samples that increase cancer detection. Lumea is advancing pathology into the…
Matthew Leavitt, MD, just co-founded the DDx Foundation. He aims to progress prostate cancer research and treatment through digital diagnostics. The other founders are pathologists E. David Crawford, MD, and…
